Fixed combinations in the management of hypertension: perspectives on lercanidipine – enalapril

References

• AgrawalRMarxAHallerH2006Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertensionJ Hypertens241859216331117
   PubMed Web of Science ®Google Scholar
• ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group2002Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA28829819712479763
   PubMed Web of Science ®Google Scholar
• BangLMChapmanTMGoaKL2003Lercanidipine: a review of its efficacy in the management of hypertensionDrugs6324497214609358
   PubMed Web of Science ®Google Scholar
• BakrisGLWilliamsMDworkinL2000Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working GroupAm J Kidney Dis366466110977801
   PubMed Web of Science ®Google Scholar
• BarriosVNavarroAEsterasA2002Antihypertensive efficacy and tolerability of lercanidipine in daily clinical practice. The ELYPSE StudyBlood Press119510012035878
   PubMed Web of Science ®Google Scholar
• BarriosVEscobarCNavarroA2006Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: The LAURA studyInt J Clin Pract6013647017073834
   PubMed Web of Science ®Google Scholar
• BarriosVBanegasJRRuilopeLM2007aEvolution of blood pressure control in SpainJ Hypertens251975717762665
   PubMed Web of Science ®Google Scholar
• BarriosVEscobarCCalderónA2007bCONTROLRISK Investigators. Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK studyJ Hum Hypertens214798517314997
   PubMed Web of Science ®Google Scholar
• BarriosVEscobarCCalderónA2007cBlood pressure and lipid goal attainment in the hypertensive population in the primary care setting in SpainJ Clin Hypertens (Greenwich)9324917485967
   PubMedGoogle Scholar
• BarriosVEscobarCCalderónA2007dPrevalence of the metabolic syndrome in patients with hypertension treated in general practice in Spain: an assessment of blood pressure and low-density lipoprotein cholesterol control and accuracy of diagnosisJ Cardiometab Syndr291517684454
   PubMedGoogle Scholar
• BarriosVEscobarCLlisterriJL2007eBlood pressure and lipid control and coronary risk in the hypertensive population attended in Primary Care setting in Spain. The PRESCOT studyRev Clin Esp207172817475179
   PubMed Web of Science ®Google Scholar
• BarriosVEscobarC2008Olmesartan medoxomil plus hydrochlorothiazide for treating hypertensionExpert Opin Pharmacother91293618076344
   PubMed Web of Science ®Google Scholar
• BarriosVEscobarCde la FigueraM2008High doses of lercanidipine are better tolerated than other dihydropyridines in hypertensive patients with metabolic syndrome: results from the TOLERANCE studyInt J Clin Pract62723818355238
   PubMed Web of Science ®Google Scholar
• BrennerBMCooperMEde ZeeuwD2001Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathyN Engl J Med345861911565518
   PubMed Web of Science ®Google Scholar
• CanavesiMBaldiniNLeonardiA2004In vitro inhibitory effect of lercanidipine on cholesterol accumulation and matrix metalloproteinases secretion by macrophagesJ Cardiovasc Pharmacol444162215454849
   PubMed Web of Science ®Google Scholar
• CherubiniAFabrisFFerrariE2003Comparative effects of lercanidipine, lacidipine, and nifedipine gastrointestinal therapeutic system on blood pressure and heart rate in elderly hypertensive patients: the ELderly and LErcanidipine (ELLE) studyArch Gerontol Geriatr372031214511846
   PubMed Web of Science ®Google Scholar
• CheungBMOngKLManYB2006Prevalence, awareness, treatment, and control of hypertension: United States National Health and Nutrition Examination Survey 2001–2002J Clin Hypertens (Greenwich)893816470077
   PubMedGoogle Scholar
• ChobanianAVBakrisGLBlackHR2003The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 reportJAMA28925607212748199
   PubMed Web of Science ®Google Scholar
• DahlöfBSeverPSPoulterNR2005Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialLancet36689590616154016
   PubMed Web of Science ®Google Scholar
• Dalla VestraMPozzaGMoscaA2004Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina)Diabetes Nutr Metab172596616295047
   PubMedGoogle Scholar
• EganBM2007Combination therapy with an angiotensin-converting enzyme inhibitor and a calcium channel blockerJ Clin Hypertens (Greenwich)97838917917506
   PubMedGoogle Scholar
• EpsteinM2001Lercanidipine: a novel dihydropyridine calcium-channel blockerHeart Dis339840711975824
   PubMedGoogle Scholar
• EstacioROSchrierRW1998Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trialAm J Cardiol829R14R
   PubMed Web of Science ®Google Scholar
• FogariRCorradiLZoppiA2007aAddition of manidipine improves the antiproteinuric effect of candesartan in hypertensive patients with type II diabetes and microalbuminuriaAm J Hypertens2010929617903693
   PubMed Web of Science ®Google Scholar
• FogariRDerosaGZoppiA2007bEffect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuriaAm J Hypertens204172217386350
   PubMed Web of Science ®Google Scholar
• FogariRMalamaniGZoppiA2007cEffect on the development of ankle edema of adding delapril to manidipine in patients with mild to moderate essential hypertension: a three-way crossover studyClin Ther294131817577462
   PubMed Web of Science ®Google Scholar
• GojanovicBFeihlFLiaudetL2008Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertensionJ Renin Angiotensin Aldosterone Syst91918404602
   PubMed Web of Science ®Google Scholar
• HairPIScottLJPerryCM2007Fixed-dose combination lercanidipine/enalaprilDrugs679510617209666
   PubMed Web of Science ®Google Scholar
• HanssonLZanchettiACarruthersSG1998Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study GroupLancet3511755629635947
   PubMed Web of Science ®Google Scholar
• HasebeNKikuchiKNICE Combi Study Group2005Controlled-release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension: the NICE Combi (Nifedipine and Candesartan Combination) StudyJ Hypertens234455315662234
   PubMed Web of Science ®Google Scholar
• HerbetteLGVecchiarelliMSartaniA1998Lercanidipine: short plasma half-life, long duration of action and high cholesterol tolerance. Updated molecular model to rationalize its pharmacokinetic propertiesBlood Press Suppl210179850437
   PubMedGoogle Scholar
• HosomiNMizushigeKOhyamaH2001Angiotensin-converting enzyme inhibition with enalapril slows progressive intima-media thickening of the common carotid artery in patients with non-insulin-dependent diabetes mellitusStroke3215394511441198
   PubMed Web of Science ®Google Scholar
• JamesIGJonesADaviesP2002A randomised, double-blind, double-dummy comparison of the efficacy and tolerability of lercanidipine tablets and losartan tablets in patients with mild to moderate essential hypertensionJ Hum Hypertens166051012149668
   PubMed Web of Science ®Google Scholar
• JuliusSKjeldsenSEBrunnerH2003VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular riskAm J Hypertens16544812850387
   PubMed Web of Science ®Google Scholar
• LazarusJMBourgoignieJJBuckalewVM1997Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study GroupHypertension29641509040451
   PubMed Web of Science ®Google Scholar
• LeonettiGMagnaniBPessinaAC2002Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensivesAm J Hypertens159324012441211
   PubMed Web of Science ®Google Scholar
• LewisEJHunsickerLGClarkeWR2001Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetesN Engl J Med3458516011565517
   PubMed Web of Science ®Google Scholar
• LiuLWangJGGongL1998Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative GroupJ Hypertens161823299869017
   PubMed Web of Science ®Google Scholar
• McInnesGT2007Antihypertensive drugs in combination: additive or greater than additive?J Hum Hypertens219141617700727
   PubMed Web of Science ®Google Scholar
• ManciaGDe BackerGDominiczakA20072007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens2511058717563527
   PubMed Web of Science ®Google Scholar
• MeredithPA1999Lercadinidipine: a novel lipophilic dihydropyridine calcium antagonist with long duration of action and high vascular selectivityExp Opin Invest Drugs8104362
   PubMedGoogle Scholar
• MesserliFH2002Vasodilatory edema: a common side effect of antihypertensive therapyCurr Cardiol Reports447982
   PubMedGoogle Scholar
• MotwaniJG2002Combining renin-angiotensin-aldosterone system blockade with diuretic therapy for treatment of hypertensionJ Renin Angiotensin Aldosterone Syst3727812228846
   PubMed Web of Science ®Google Scholar
• NesbittSD2007Antihypertensive combination therapy: optimizing blood pressure control and cardiovascular risk reductionJ Clin Hypertens (Greenwich)911 Suppl 4263217978604
   PubMedGoogle Scholar
• NissenSETuzcuEMLibbyP2004Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trialJAMA29222172515536108
   PubMed Web of Science ®Google Scholar
• OngKLCheungBMManYB2007Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004Hypertension49697517159087
   PubMed Web of Science ®Google Scholar
• OteroML2007Manidipine-delapril combination in the management of hypertensionVasc Health Risk Manag32556317703633
   PubMedGoogle Scholar
• PoldermansDGlazesRKargiannisS2007Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertensionClin Ther292798917472820
   PubMed Web of Science ®Google Scholar
• PuigJGCalvoCLuurilaO2007Lercanidipine, enalapril and their combination in the treatment of elderly hypertensive patients: placebo-controlled, randomized, crossover study with four ABPMJ Hum Hypertens219172417581601
   PubMed Web of Science ®Google Scholar
• RachmaniRLeviZZadokBS2002Losartan and lercanidipine attenuate low-density lipoprotein oxidation in patients with hypertension and type 2 diabetes mellitus: a randomized, prospective crossover studyClin Pharmacol Ther72302712235451
   PubMed Web of Science ®Google Scholar
• RavidMBroshDLeviZ1998Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trialAnn Intern Med12898289625684
   PubMed Web of Science ®Google Scholar
• Recordati SpA2004aEfficacy and tolerability of a combination of lercanidipine and enalapril in patients with mild to moderate essential hypertension not adequately controlled by lercanidipine treatment (add-on to lercanidipine) [CPL1-0018]MilanRecordati SpA311[Data on file].
   Google Scholar
• Recordati SpA2004bEfficacy and tolerability of a combination of lercanidipine and enalapril in patients with mild to moderate essential hypertension not adequately controlled by enalapril treatment (add-on to enalapril) [CPL1-0019]MilanRecordati SpA325[Data on file].
   Google Scholar
• RoblesNROconJGomezCF2005Lercanidipine in patients with chronic renal failure: the ZAFRA studyRen Fail27738015717638
   PubMed Web of Science ®Google Scholar
• RoblesNRPastorLManjónM2004Lercanidipine in diabetic patients with renal failureNefrologia243384315455493
   PubMed Web of Science ®Google Scholar
• RomitoRPansiniMIPerticoneF2003Comparative effect of lercanidipine, felodipine, and nifedipine GITS on blood pressure and heart rate in patients with mild to moderate arterial hypertension: the Lercanidipine in Adults (LEAD) StudyJ Clin Hypertens (Greenwich)52495312939564
   PubMedGoogle Scholar
• RoseiEARizzoniDMuiesanML2005Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitusJ Hypertens234354415662233
   PubMed Web of Science ®Google Scholar
• RydenLStandlEBartnikM2007Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)Eur Heart J288813617220161
   PubMed Web of Science ®Google Scholar
• SicaDA2002Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeatsDrugs624462
   Web of Science ®Google Scholar
• SomaMRNataliMDonettiE1998Effect of lercanidipine and its (R)-enantiomer on atherosclerotic lesions induced in hypercholesterolemic rabbitsBr J Pharmacol125147169884075
   PubMed Web of Science ®Google Scholar
• SowersJRBakrisGLBlackHR2007The cardiometabolic syndrome and calcium channel blocker combination drugsJ Cardiometab Syndr22071217786085
   PubMedGoogle Scholar
• StaessenJAFagardRThijsL1997Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial InvestigatorsLancet350757649297994
   PubMed Web of Science ®Google Scholar
• ToddPAGoaKL1992Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertensionDrugs43346811374319
   PubMed Web of Science ®Google Scholar
• ToddPAHeelRCEnalapril1986A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failureDrugs311982483011386
   PubMed Web of Science ®Google Scholar
• UKPDS 381998Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study GroupBMJ317703139732337
   PubMed Web of Science ®Google Scholar
• WangYRAlexanderGCStaffordRS2007Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United StatesArch Intern Med167141717242314
   PubMed Web of Science ®Google Scholar
• WeirMRRosenbergerCFinkJC2001Pilot study to evaluate a water displacement technique to compare effects of diuretics and ACE inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonistsAm J Hypertens14963811587165
   PubMed Web of Science ®Google Scholar